secwatch.observer — SEC 8-K summary
======================================

Issuer:     BAXTER INTERNATIONAL INC (BAX)
CIK:        0000010456
Form:       8-K
Filed at:   2026-07-14T20:15:49+00:00
Accession:  0001628280-26-048158
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baxter changes reportable segments to two: MPT and HST, effective Q2 2026
-------------------------------------------------------------------------

- Former Pharmaceuticals segment moved into Infusion Therapies & Platforms division of MPT.
- Certain manufacturing facility sales previously in Other now reported in ITP division.
- Corporate cost allocation updated: some shared expenses now remain unallocated.
- Recast historical segment data for 2024, 2025, and Q1 2026 provided in Exhibit 99.1.
- No impact on consolidated net income, EPS, total assets, or stockholders' equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10456/000162828026048158/0001628280-26-048158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10456/000162828026048158/bax-20260714.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-048158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer